Essential fatty acids and the skin.
D000169:Acrodermatitis / Q000378:metabolism; D000287:Administration, Topical; D000328:Adult; D000818:Animals; D001095:Arachidonic Acids / Q000172:deficiency; D004285:Dogs; D005228:Fatty Acids, Essential / Q000172:deficiency* / Q000378:metabolism; D006801:Humans; D006965:Hyperplasia; D007223:Infant; D008041:Linoleic Acids / Q000008:administration & dosage / Q000172:deficiency / Q000627:therapeutic use; D051379:Mice; D011453:Prostaglandins / Q000096:biosynthesis; D011458:Prostaglandins E / Q000627:therapeutic use; D051381:Rats; D012867:Skin / Q000378:metabolism*; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology / Q000473:pathology
D001095:Arachidonic Acids; D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D011453:Prostaglandins; D011458:Prostaglandins E